Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism

Circulation - United States
doi 10.1161/circulationaha.111.051920
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Circumstances of Provoked Recurrent Venous Thromboembolism: The Austrian Study on Recurrent Venous Thromboembolism

Journal of Thrombosis and Thrombolysis
Cardiovascular MedicineHematologyCardiology
2019English

Treating Venous Thromboembolism in Patients With Cancer

Expert Review of Hematology
Hematology
2012English

Prevention of Venous Thromboembolism in Cancer Patients

Egyptian Journal of Hematology and Bone Marrow Transplantation
2015English

A Risk Score for Prediction of Recurrence in Patients With Unprovoked Venous Thromboembolism (DAMOVES)

European Journal of Internal Medicine
Internal Medicine
2016English

Venous Thromboembolism Prophylaxis in Cancer Patients

2012English

Risk of Cancer in Patients With Thyroid Disease and Venous Thromboembolism

Clinical Epidemiology
Epidemiology
2018English

The Risk of Recurrent Venous Thromboembolism in Heterozygous Carriers of Factor v Leiden and a First Spontaneous Venous Thromboembolism

Archives of Internal Medicine
2002English

Venous Thromboembolism an Observational Study to Assess the Risk of Venous Thromboembolism in Surgical Patients.

The Professional Medical Journal
2019English

Prevention of Recurrent Idiopathic Venous Thromboembolism

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy